CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor

Virology

Volumn 302, Issue 2, 2002, Pages 342-353

  Vermeire, Kurt ^a   Zhang, Ying ^a   Princen, Katrien ^a   Hatse, Sigrid ^a   Samala, Meinrado F ^b   Dey, Kaka ^b   Choi, Heung Jin ^d   Ahn, Youngmi ^c   Sodoma, Andrej ^b   Snoeck, Robert ^a   Andrei, Graciela ^a   De Clercq, Erik ^a   Bell, Thomas W ^b   Schols, Dominique ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF NEVADA   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d Kyungpook National University   (South Korea)

Author keywords

Antiviral; CD4 receptor; Down modulation; HHV 7; HIV

Indexed keywords

9 BENZYL 3 METHYLENE 1,5 DI 4 TOLUENESULFONYL 1,5,9 TRIAZACYCLODODECANE; ANTIVIRUS AGENT; AURINTRICARBOXYLIC ACID; CD11B ANTIGEN; CD2 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 7; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; T LYMPHOCYTE; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN;

HERPESVIRIDAE; HUMAN HERPESVIRUS 7; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036436747     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1624     Document Type: Article

References (47)

1. Acres, R. B., Conlon, P. J., Mochizuki, D. Y., and Gallis, B. (1986). Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen. J. Biol. Chem. 261, 16210-16214.
2. Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., Meguro, K., and Fujino, M. (1999). A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl. Acad. Sci. USA 96, 5698-5703.
3. Bridger, G. J., Skerlj, R. T., Thornton, D., Padmanabhan, S., Martellucci, S. A., Henson, G. W., Abrams, M. J., Yamamoto, N., De Vreese, K., Pauwels, R., and De Clercq, E. (1995). Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker. J. Med. Chem. 38, 366-378.
4. Chan, D. C., Chutkowski, C. T., and Kim, P. S. (1998). Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc. Natl. Acad. Sci. USA 95, 15613-15617.
5. Chieco-Bianchi, L., Calabro, M. L., Panozzo, M., De Rossi, A., Amadori, A., Callegaro, L., and Siccardi, A. (1989). CD4 modulation and inhibition of HIV-1 infectivity induced by monosialoganglioside GM1 in vitro. AIDS 3, 501-507.
6. Choi, H.-J. (1989). Ph.D. thesis. State University of New York, Stony Brook, NY.
7. Chowdhury, I. H., Koyanagi, Y., Kobayashi, S., Hamamoto, Y., Yoshiyama, H., Yoshida, T., and Yamamoto, N. (1990). The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: Possible involvement of protein kinase C pathway. Virology 176, 126-132.
8. Clapham, P. R., Blanc, D., and Weiss, R. A. (1991). Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus. Virology 181, 703-715.
9. Dalgleish, A. G., Beverley, P. C., Clapham, P. R., Crawford, D. H., Greaves, M. F., and Weiss, R. A. (1984). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767.
10. Davis, K. A., Abrams, B., Iyer, S. B., Hoffman, R. A., and Bishop, J. E. (1998). Determination of CD4 antigen density on cells: Role of antibody valency, avidity, clones, and conjugation. Cytometry 33, 197-205.
11. De Vreese, K., Kofler-Mongold, V., Leutgeb, C., Weber, V., Vermeire, K., Schacht, S., Anné, J., De Clercq, E., Datema, R., and Werner, G. (1996). The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. J. Virol. 70, 689-696.
12. Edwards, T. G., Hoffman, T. L., Baribaud, F., Wyss, S., LaBranche, C. C., Romano, J., Adkinson, J., Sharron, M., Hoxie, J. A., and Doms, R. W. (2001). Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. J. Virol. 75, 5230-5239.
13. Esté, J. A., Schols, D., De Vreese, K., Van Laethem, K., Vandamme, A. M., Desmyter, J., and De Clercq, E. (1997). Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein. Mol. Pharmacol. 52, 98-104.
14. + T cells. J. Immunol. 152, 5768-5775.
15. Golding, H., Manischewitz, J., Vujcic, L., Blumenthal, R., and Dimitrov, D. S. (1994). The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells. J. Virol. 68, 1962-1969.
16. Hoffman, T. L., LaBranche, C. C., Zhang, W., Canziani, G., Robinson, J., Chaiken, I., Hoxie, J. A., and Doms, R. W. (1999). Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. Proc. Natl. Acad. Sci. USA 96, 6359-6364.
17. Hoxie, J. A., Matthews, D. M., Callahan, K. J., Cassel, D. L., and Cooper, R. A. (1986). Transient modulation and internalization of T4 antigen induced by phorbol esters. J. Immunol. 137, 1194-1201.
18. Jiang, S., Lin, K., Strick, N., and Neurath, A. R. (1993). HIV-1 inhibition by a peptide. Nature 365, 113.
19. Kabat, D., Kozak, S. L., Wehrly, K., and Chesebro, B. (1994). Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J. Virol. 68, 2570-2577.
20. Kawaguchi, T., Nakakuma, H., Kagimoto, T., Shirono, K., Horikawa, K., Hidaka, M., Iwamori, M., Nagai, Y., and Takatsuki, K. (1989). Characteristic mode of action of gangliosides in selective modulation of CD4 on human T lymphocytes. Biochem. Biophys. Res. Commun. 158, 1050-1059.
21. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J. C., and Montagnier, L. (1984). T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768.
22. Kolchinsky, P., Kiprilov, E., and Sodroski, J. (2001). Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants. J. Virol. 75, 2041-2050.
23. Layne, S. P., Merges, M. J., Dembo, M., Spouge, J. L., and Nara, P. L. (1990). HIV requires multiple gp120 molecules for CD4-mediated infection. Nature 346, 277-279.
24. Li, S., Satoh, T., Korngold, R., and Huang, Z. (1998). CD4 dimerization and oligomerization: Implications for T-cell function and structure-based drug design. Immunol. Today 19, 455-462.
25. Lusso, P., Secchiero, P., Crowley, R. W., Garzino-Demo, A., Berneman, Z. N., and Gallo, R. C. (1994). CD4 is a critical component of the receptor for human herpesvirus 7: Interference with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 91, 3872-3876.
26. Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A., and Axel, R. (1986). The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333-348.
27. Maddon, P. J., Littman, D. R., Godfrey, M., Maddon, D. E., Chess, L., and Axel, R. (1985). The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: A new member of the immunoglobulin gene family. Cell 42, 93-104.
28. Neudorf, S., DeLaat, C., and Jones, M. (1989). Expression of the CD4 molecule on acute nonlymphocytic leukemia (ANLL) cell lines. J. Clin. Lab. Anal. 3, 312-315.
29. Neudorf, S., Jones, M., Parker, S., Papes, R., and Lattier, D. (1991). Phorbol esters down-regulate transcription and translation of the CD4 gene. J. Immunol. 146, 2836-2840.
30. Offner, H., Thieme, T., and Vandenbark, A. A. (1987). Gangliosides induce selective modulation of CD4 from helper T lymphocytes. J. Immunol. 139, 3295-3305.
31. Piguet, V., Schwartz, O., Le Gall, S., and Trono, D. (1999). The down-regulation of CD4 and MHC-I by primate lentiviruses: A paradigm for the modulation of cell surface receptors. Immunol. Rev. 168, 51-63.
32. Platt, E. J., Kozak, S. L., and Kabat, D. (2000). Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 16, 871-882.
33. Platt, E. J., Madani, N., Kozak, S. L., and Kabat, D. (1997). Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor. J. Virol. 71, 883-890.
34. Poulin, L., Evans, L. A., Tang, S. B., Barboza, A., Legg, H., Littman, D. R., and Levy, J. A. (1991). Several CD4 domains can play a role in human immunodeficiency virus infection in cells. J. Virol. 65, 4893-4901.
35. Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (London) 313, 277-284.
36. Samala, M. F. (1999). Ph.D. thesis. University of Nevada, Reno, NV.
37. Schols, D., Baba, M., Pauwels, R., Desmyter, J., and De Clercq, E. (1989a). Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc. Natl. Acad. Sci. USA 86, 3322-3326.
38. Schols, D., Esté, J. A., Cabrera, C., and De Clercq, E. (1998). T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1 α contains mutations in the envelope gp120 but does not show a switch in coreceptor use. J. Virol. 72, 4032-4037.
39. + cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry. J. Gen. Virol. 70, 2397-2408.
40. Schols, D., Struyf, S., Van Damme, J., Esté, J. A., Henson, G., and De Clercq, E. (1997). Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med. 186, 1383-1388.
41. lck levels. J. Immunol. 159, 3412-3423.
42. Signoret, N., Oldridge, J., Pelchen-Matthews, A., Klasse, P. J., Tran, T., Brass, L. F., Rosenkilde, M. M., Schwartz, T. W., Holmes, W., Dallas, W., Luther, M. A., Wells, T. N., Hoxie, J. A., and Marsh, M. (1997). Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J. Cell Biol. 139, 651-664.
43. Sodoma, A. (1996). Ph.D. thesis. State University of New York, Stony Brook, NY.
44. 1. Thymus 20, 239-248.
45. Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., and Matthews, T. J. (1994). Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91, 9770-9774.
46. Yasukawa, M., Inoue, Y., Sada, E., Yakushijin, Y., Furukawa, M., and Fujita, S. (1995). CD4 down-modulation by ganglioside and phorbol ester inhibits human herpesvirus 7 infection. J. Gen. Virol. 76, 2381-2385.
47. Zhang, Y., Schols, D., and De Clercq, E. (1999). Selective activity of various antiviral compounds against HHV-7 infection. Antiviral Res. 43, 23-35.